Logo image of CTAS

CINTAS CORP (CTAS) Stock Fundamental Analysis

NASDAQ:CTAS - Nasdaq - US1729081059 - Common Stock - Currency: USD

204.43  -1.5 (-0.73%)

After market: 204 -0.43 (-0.21%)

Fundamental Rating

7

CTAS gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. CTAS has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. While showing a medium growth rate, CTAS is valued expensive at the moment. With these ratings, CTAS could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

CTAS had positive earnings in the past year.
In the past year CTAS had a positive cash flow from operations.
CTAS had positive earnings in each of the past 5 years.
In the past 5 years CTAS always reported a positive cash flow from operatings.
CTAS Yearly Net Income VS EBIT VS OCF VS FCFCTAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

With an excellent Return On Assets value of 18.22%, CTAS belongs to the best of the industry, outperforming 98.78% of the companies in the same industry.
CTAS has a better Return On Equity (39.74%) than 97.56% of its industry peers.
The Return On Invested Capital of CTAS (24.03%) is better than 97.56% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CTAS is significantly above the industry average of 10.12%.
The last Return On Invested Capital (24.03%) for CTAS is above the 3 year average (20.29%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 18.22%
ROE 39.74%
ROIC 24.03%
ROA(3y)15.96%
ROA(5y)14.52%
ROE(3y)36.06%
ROE(5y)32.99%
ROIC(3y)20.29%
ROIC(5y)18.5%
CTAS Yearly ROA, ROE, ROICCTAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

The Profit Margin of CTAS (17.16%) is better than 95.12% of its industry peers.
In the last couple of years the Profit Margin of CTAS has grown nicely.
CTAS has a Operating Margin of 22.34%. This is amongst the best in the industry. CTAS outperforms 93.90% of its industry peers.
In the last couple of years the Operating Margin of CTAS has grown nicely.
CTAS has a better Gross Margin (49.62%) than 87.80% of its industry peers.
In the last couple of years the Gross Margin of CTAS has remained more or less at the same level.
Industry RankSector Rank
OM 22.34%
PM (TTM) 17.16%
GM 49.62%
OM growth 3Y3.33%
OM growth 5Y5.29%
PM growth 3Y1.71%
PM growth 5Y5.13%
GM growth 3Y1.59%
GM growth 5Y1.47%
CTAS Yearly Profit, Operating, Gross MarginsCTAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CTAS is creating value.
CTAS has more shares outstanding than it did 1 year ago.
CTAS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CTAS has an improved debt to assets ratio.
CTAS Yearly Shares OutstandingCTAS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CTAS Yearly Total Debt VS Total AssetsCTAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 13.49 indicates that CTAS is not in any danger for bankruptcy at the moment.
CTAS has a Altman-Z score of 13.49. This is amongst the best in the industry. CTAS outperforms 97.56% of its industry peers.
CTAS has a debt to FCF ratio of 1.43. This is a very positive value and a sign of high solvency as it would only need 1.43 years to pay back of all of its debts.
CTAS has a better Debt to FCF ratio (1.43) than 81.71% of its industry peers.
A Debt/Equity ratio of 0.47 indicates that CTAS is not too dependend on debt financing.
CTAS's Debt to Equity ratio of 0.47 is in line compared to the rest of the industry. CTAS outperforms 52.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1.43
Altman-Z 13.49
ROIC/WACC2.68
WACC8.97%
CTAS Yearly LT Debt VS Equity VS FCFCTAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.3 Liquidity

CTAS has a Current Ratio of 1.58. This is a normal value and indicates that CTAS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.58, CTAS is in line with its industry, outperforming 57.32% of the companies in the same industry.
CTAS has a Quick Ratio of 1.38. This is a normal value and indicates that CTAS is financially healthy and should not expect problems in meeting its short term obligations.
CTAS has a Quick ratio (1.38) which is comparable to the rest of the industry.
The current and quick ratio evaluation for CTAS is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.38
CTAS Yearly Current Assets VS Current LiabilitesCTAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.39% over the past year.
CTAS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.78% yearly.
The Revenue has grown by 8.12% in the past year. This is quite good.
Measured over the past years, CTAS shows a small growth in Revenue. The Revenue has been growing by 6.84% on average per year.
EPS 1Y (TTM)20.39%
EPS 3Y13.92%
EPS 5Y14.78%
EPS Q2Q%20.78%
Revenue 1Y (TTM)8.12%
Revenue growth 3Y10.48%
Revenue growth 5Y6.84%
Sales Q2Q%7.77%

3.2 Future

The Earnings Per Share is expected to grow by 11.48% on average over the next years. This is quite good.
Based on estimates for the next years, CTAS will show a small growth in Revenue. The Revenue will grow by 7.70% on average per year.
EPS Next Y16.51%
EPS Next 2Y13.42%
EPS Next 3Y12.67%
EPS Next 5Y11.48%
Revenue Next Year7.37%
Revenue Next 2Y7.28%
Revenue Next 3Y7.2%
Revenue Next 5Y7.7%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CTAS Yearly Revenue VS EstimatesCTAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
CTAS Yearly EPS VS EstimatesCTAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 49.26 indicates a quite expensive valuation of CTAS.
CTAS's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 29.63, CTAS is valued quite expensively.
Based on the Price/Forward Earnings ratio of 41.99, the valuation of CTAS can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as CTAS.
CTAS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.68.
Industry RankSector Rank
PE 49.26
Fwd PE 41.99
CTAS Price Earnings VS Forward Price EarningsCTAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CTAS is valued a bit more expensive than the industry average as 68.29% of the companies are valued more cheaply.
The rest of the industry has a similar Price/Free Cash Flow ratio as CTAS.
Industry RankSector Rank
P/FCF 44.47
EV/EBITDA 31.81
CTAS Per share dataCTAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CTAS has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CTAS's earnings are expected to grow with 12.67% in the coming years.
PEG (NY)2.98
PEG (5Y)3.33
EPS Next 2Y13.42%
EPS Next 3Y12.67%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.76%, CTAS is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.12, CTAS pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.76, CTAS pays less dividend than the S&P500 average, which is at 2.29.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

The dividend of CTAS decreases each year by -0.11%.
CTAS has been paying a dividend for at least 10 years, so it has a reliable track record.
CTAS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-0.11%
Div Incr Years3
Div Non Decr Years3
CTAS Yearly Dividends per shareCTAS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

33.44% of the earnings are spent on dividend by CTAS. This is a low number and sustainable payout ratio.
DP33.44%
EPS Next 2Y13.42%
EPS Next 3Y12.67%
CTAS Yearly Income VS Free CF VS DividendCTAS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
CTAS Dividend Payout.CTAS Dividend Payout, showing the Payout Ratio.CTAS Dividend Payout.PayoutRetained Earnings

CINTAS CORP

NASDAQ:CTAS (2/21/2025, 8:11:12 PM)

After market: 204 -0.43 (-0.21%)

204.43

-1.5 (-0.73%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)12-19 2024-12-19/bmo
Earnings (Next)03-25 2025-03-25/amc
Inst Owners66.94%
Inst Owner Change4.75%
Ins Owners1.79%
Ins Owner Change0.03%
Market Cap82.50B
Analysts71.2
Price Target205.68 (0.61%)
Short Float %1.23%
Short Ratio2.12
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend2.1
Dividend Growth(5Y)-0.11%
DP33.44%
Div Incr Years3
Div Non Decr Years3
Ex-Date02-14 2025-02-14 (0.39)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.23%
Min EPS beat(2)5.32%
Max EPS beat(2)13.14%
EPS beat(4)4
Avg EPS beat(4)6.71%
Min EPS beat(4)3.09%
Max EPS beat(4)13.14%
EPS beat(8)7
Avg EPS beat(8)3.81%
EPS beat(12)11
Avg EPS beat(12)4.08%
EPS beat(16)15
Avg EPS beat(16)4.52%
Revenue beat(2)0
Avg Revenue beat(2)-1.87%
Min Revenue beat(2)-2.04%
Max Revenue beat(2)-1.71%
Revenue beat(4)0
Avg Revenue beat(4)-1.68%
Min Revenue beat(4)-2.04%
Max Revenue beat(4)-1.14%
Revenue beat(8)0
Avg Revenue beat(8)-1.21%
Revenue beat(12)4
Avg Revenue beat(12)-0.44%
Revenue beat(16)4
Avg Revenue beat(16)-0.54%
PT rev (1m)-3.23%
PT rev (3m)-3.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-75.1%
EPS NY rev (1m)0.11%
EPS NY rev (3m)2.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 49.26
Fwd PE 41.99
P/S 8.3
P/FCF 44.47
P/OCF 36.53
P/B 19.22
P/tB 171.57
EV/EBITDA 31.81
EPS(TTM)4.15
EY2.03%
EPS(NY)4.87
Fwd EY2.38%
FCF(TTM)4.6
FCFY2.25%
OCF(TTM)5.6
OCFY2.74%
SpS24.63
BVpS10.64
TBVpS1.19
PEG (NY)2.98
PEG (5Y)3.33
Profitability
Industry RankSector Rank
ROA 18.22%
ROE 39.74%
ROCE 30.18%
ROIC 24.03%
ROICexc 24.44%
ROICexgc 51.64%
OM 22.34%
PM (TTM) 17.16%
GM 49.62%
FCFM 18.66%
ROA(3y)15.96%
ROA(5y)14.52%
ROE(3y)36.06%
ROE(5y)32.99%
ROIC(3y)20.29%
ROIC(5y)18.5%
ROICexc(3y)20.86%
ROICexc(5y)19.2%
ROICexgc(3y)43.4%
ROICexgc(5y)41.05%
ROCE(3y)25.49%
ROCE(5y)23.23%
ROICexcg growth 3Y2.7%
ROICexcg growth 5Y9.17%
ROICexc growth 3Y7.28%
ROICexc growth 5Y9.85%
OM growth 3Y3.33%
OM growth 5Y5.29%
PM growth 3Y1.71%
PM growth 5Y5.13%
GM growth 3Y1.59%
GM growth 5Y1.47%
F-Score8
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 1.43
Debt/EBITDA 0.75
Cap/Depr 85.51%
Cap/Sales 4.06%
Interest Coverage 250
Cash Conversion 83.88%
Profit Quality 108.72%
Current Ratio 1.58
Quick Ratio 1.38
Altman-Z 13.49
F-Score8
WACC8.97%
ROIC/WACC2.68
Cap/Depr(3y)77.9%
Cap/Depr(5y)66.29%
Cap/Sales(3y)3.7%
Cap/Sales(5y)3.27%
Profit Quality(3y)102.17%
Profit Quality(5y)107.82%
High Growth Momentum
Growth
EPS 1Y (TTM)20.39%
EPS 3Y13.92%
EPS 5Y14.78%
EPS Q2Q%20.78%
EPS Next Y16.51%
EPS Next 2Y13.42%
EPS Next 3Y12.67%
EPS Next 5Y11.48%
Revenue 1Y (TTM)8.12%
Revenue growth 3Y10.48%
Revenue growth 5Y6.84%
Sales Q2Q%7.77%
Revenue Next Year7.37%
Revenue Next 2Y7.28%
Revenue Next 3Y7.2%
Revenue Next 5Y7.7%
EBIT growth 1Y15.8%
EBIT growth 3Y14.15%
EBIT growth 5Y12.5%
EBIT Next Year37.92%
EBIT Next 3Y18.04%
EBIT Next 5Y14.12%
FCF growth 1Y44.43%
FCF growth 3Y11.13%
FCF growth 5Y16.12%
OCF growth 1Y44.49%
OCF growth 3Y15.19%
OCF growth 5Y14.26%